Helius - Latest News [Page 1]
Director Of Innovation & Productivity Appointed At Helius
Wednesday, 17 November 2021, 11:38 am | Helius
Angela Freiden has been appointed Director of Innovation & Productivity at Helius Therapeutics, New Zealand’s largest licenced medicinal cannabis company. <img src="https://img.scoop.co.nz/stories/images/2111/1bf550adae1b5b847f5e.jpeg" ... More >>
Helius Appoints Director Of R&D
Tuesday, 9 November 2021, 9:20 am | Helius
Marten Vos has been appointed Director of Research & Development at Helius Therapeutics. <img src="https://img.scoop.co.nz/stories/images/2111/eb90ee84abb980773c82.jpeg" width="720" height="540"> “Helius is squarely focused ... More >>
Helius Gains NZ’s First Licence To Manufacture Cannabis Medicines
Wednesday, 4 August 2021, 9:19 am | Helius
New Zealand’s largest licenced medicinal cannabis company, Helius Therapeutics, has been issued with the industry’s first GMP (Good Manufacturing Practice) Licence to Manufacture Medicines by MedSafe. It allows the company to begin manufacturing ... More >>
Chief Commercial Officer At Helius Announced
Tuesday, 18 May 2021, 10:39 am | Helius
Mark Morrison has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics - New Zealand’s largest licenced medicinal cannabis company. <img src="https://img.scoop.co.nz/stories/images/2105/5a2620250ffd33709348.jpeg" width="540" height="720"> Mark Morrison For six months ... More >>
Helius Appoints Chief Financial Officer
Sunday, 9 August 2020, 11:29 am | Helius
New Zealand’s largest licensed medicinal cannabis company, Helius Therapeutics, has appointed Mark Woods as its Chief Financial Officer (CFO). He joins Helius after 11 years in financial and commercial leadership roles at Fonterra. Most recently ... More >>
Cannabis for pets, a first for New Zealand
Thursday, 21 May 2020, 9:55 am | Helius
Local company, Helius Group, is launching New Zealand’s first ever medicinal cannabis for pets’ product range with the establishment of Helius Animal Health. The new business will operate alongside the country’s largest medicinal cannabis company, ... More >>
Helius appoints Chief Quality Officer
Friday, 14 February 2020, 9:33 am | Helius
His previous role was with contract medicines manufacturer, Argenta, where he was Global Head of Quality, with responsibility for quality and GMP compliance at the company’s US, UK, and New Zealand sites. More >>
Legalised personal cannabis use would be tightly regulated
Thursday, 5 December 2019, 2:55 pm | Helius
The Government’s approach to legalising personal cannabis use would provide many opportunities for new businesses, boost tax revenue, and deliver quality standards in a safer and more open environment. As the proposed legislation’s name suggests, ... More >>
Tracking survey: Support lifts for personal cannabis use
Sunday, 1 December 2019, 12:11 pm | Helius
Support for legalising personal cannabis use has risen by 9% in the past quarter, according to the country’s only 12-month tracking survey on how New Zealanders would vote in the Government's binding referendum next year. More >>
Helius appoints Group Financial Controller
Monday, 18 November 2019, 10:29 am | Helius
Mr Williams has joined New Zealand’s largest medicinal cannabis company after holding a number of financial leadership roles - from managing high-growth start-ups to serving as Chief Financial Officer of a well-established NZX-listed company. More >>
Leading pain specialist’s cannabis role
Monday, 4 November 2019, 2:29 pm | Helius
“The appointment of a leading pain specialist to New Zealand’s largest licensed medicinal cannabis company is great news for the many Kiwis suffering from chronic pain,” says Paul Manning, Co-Chief Executive of Helius Therapeutics. More >>
Helius appoints Quality Manager
Monday, 14 October 2019, 12:10 pm | Helius
Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well as the quality of all manufactured medicinal cannabis products. More >>
Helius appoints Quality Manager
Monday, 14 October 2019, 9:42 am | Helius
Helius Therapeutics has appointed Keryn Davies as its Quality Manager. She will ensure pharmaceutical and regulatory compliance, as well as the quality of all manufactured medicinal cannabis products. More >>
Support to legalise recreational cannabis in decline
Saturday, 17 August 2019, 10:38 am | Helius
The prospect of ending wider cannabis prohibition looks increasingly unlikely. Over the last nine months, the percentage of New Zealanders who would vote for legalising the personal use of cannabis has declined at a near linear rate of around 10% per ... More >>
Medicinal cannabis advocates need to have their say today
Wednesday, 7 August 2019, 10:33 am | Helius
With public consultation closing tonight, the country’s largest licensed medicinal cannabis company, Helius Therapeutics, is urging Kiwis to have their say on the Ministry of Health’s discussion document for New Zealand’s Medicinal Cannabis Scheme. More >>
Specialist sign-off for cannabis would strain health sector
Friday, 2 August 2019, 12:35 pm | Helius
An independent survey of over 700 healthcare professionals reveals genuine concern that New Zealand’s health sector would struggle to cope if ‘specialist sign-off’ is required before a GP can prescribe medicinal cannabis. More >>
Specialist sign-off for cannabis would strain health sector
Friday, 2 August 2019, 12:06 pm | Helius
An independent survey of over 700 healthcare professionals reveals genuine concern that New Zealand’s health sector would struggle to cope if ‘specialist sign-off’ is required before a GP can prescribe medicinal cannabis. More >>
Visiting cannabis expert warns against specialist sign-off
Sunday, 21 July 2019, 12:09 pm | Helius
“The prospect of a specialist recommendation being required before a GP can prescribe medicinal cannabis would be a huge error for New Zealand,” says British neurologist and Europe’s pre-eminent medicinal cannabis expert, Professor Mike Barnes. More >>
Cannabis scheme heading in the right direction
Thursday, 11 July 2019, 8:53 am | Helius
“New Zealanders fought hard to achieve strong parliamentary support for medicinal cannabis last year. It’s now really important people have their say on the design of the regulations to ensure sound and sensible patient access,” says Paul Manning, ... More >>
Cannabis scheme heading in the right direction
Wednesday, 10 July 2019, 6:30 pm | Helius
“New Zealanders fought hard to achieve strong parliamentary support for medicinal cannabis last year. It’s now really important people have their say on the design of the regulations to ensure sound and sensible patient access,” says Paul Manning, ... More >>